NKTR-214
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for NKTR-214, covering 2021-07-29 to 2025-10-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study of NKTR-214 in Combination With Nivolumab in Patients With Metastatic and/or Locally Advanced Sarcoma [Phase 2]